The Traderszone Network

Published in TZ Latest News 12 April, 2016 by The TZ Newswire Staff

Is it too Late to Invest in Synergy Pharmaceuticals? (SGYP)

Discover an upstart biotechnology stock trading near its 52-week low with a promising pipeline drug that may gain FDA approval by late 2016.